Immunology
🇪🇺 EMA Page 2EMA news and analysis for pharmaceutical BD, investment, and market access · 6 articles on this page
Gain critical insights into global immunology drug development, market trends, and regulatory landscapes. Inform your pharma BD and investment strategy.
Showing 13–18 of 18 articles
Roche's Gazyva Receives FDA Acceptance for Lupus Treatment Following Positive Phase III Trial Results
SAB Biotherapeutics SAB-142 Shows C-Peptide Preservation in Type 1 Diabetes Phase 1 Trial
Pharma Partnering EU 2026: Biotech BD&L Trends to Watch
Eupraxia Pharmaceuticals Reports Positive 36-Week Data from Highest Dose Cohort in Eosinophilic Esophagitis RESOLVE Trial
Cigna Healthcare Adds Accord BioPharma's IMULDOSA Biosimilar to Preferred Coverage Plans
Sanofi's Nuvaxovid COVID-19 Vaccine Shows Superior Tolerability Over mNEXSPIKE in Phase 4 Study